Skip to main content

Advertisement

Log in

Posterior reversible encephalopathy syndrome (PRES) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis

  • Nephrology - Case Report
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Posterior reversible encephalopathy syndrome (PRES) is characterized by abnormalities in cerebral white matter and neurologic symptoms. It can be caused by immunosuppressive drugs or autoimmune diseases. We describe a case of PRES in a patient with collapsing focal glomeruloesclerosis (collapsing FGS) with complete recovery after withdrawal of cyclosporine (CSA).

Case report

A 27-year-old male presented a corticosteroid-resistant nephrotic syndrome secondary to collapsing FGS corticosteroid. Treatment with CSA was started after a nonresponding course of prednisone. Three weeks later, he developed an abrupt elevation of blood pressure (210/120 mmHg), with headaches, mental confusion, and generalized seizures. Magnetic resonance imaging (MRI) showed lesions suggestive of PRES. CSA was withdrawn, and a new MRI was normal after 2 months.

Conclusions

PRES is a rare syndrome that must be suspected in every patient presenting neurologic symptoms in the course of immunosuppression. It can be induced by CSA and is totally reversible when the drug is rapidly withdrawn.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Heiss S, Krampla W, Klauser-Braun R (2006) A patient recent transplanted with a living donor kidney develops severe neurological symptoms. Nephrol Dial Transplant 21:2017–2019

    Article  PubMed  Google Scholar 

  2. Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500

    Article  PubMed  CAS  Google Scholar 

  3. Garg RK (2001) Posterior leukoencephalopathy syndrome. Postgrad Med J 77:24–28

    Article  PubMed  CAS  Google Scholar 

  4. Adams DH, Ponsford S, Gunson B et al (1987) Neurological complications following liver transplantation. Lancet 1:949–951

    Article  PubMed  CAS  Google Scholar 

  5. Antunes NL, Small TN, George D, Boulad F, Lis E (1999) Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 20:241–243

    Article  PubMed  CAS  Google Scholar 

  6. El Karoui K, Le Quintrec M, Dekeyser E, Servais A, Hummel A, Fadel F, Fakhouri F (2008) Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. Nephrol Dial Transplant 23:757–763

    Article  PubMed  Google Scholar 

  7. Cosottini M, Lazzarotti G, Ceravolo R, Michelassi MC, Canapicchi R, Murri L (2003) Cyclosporine-related posterior reversible encephalopathy syndrome (PRES) in non-transplant patient: a case report and literature review. Eur J Neurol 10:461–462

    Article  PubMed  CAS  Google Scholar 

  8. Sheashaa H, Mahmoud I, El-Basuony F et al (2007) Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study. Int Urol Nephrol 39:923–928

    Article  PubMed  CAS  Google Scholar 

  9. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65:205–210

    Article  PubMed  Google Scholar 

  10. Lim MH, Kim DW, Cho HS, Lee HJ, Kim HJ, Park KJ, Chang SH, Park DJ (2008) Isolated cerebellar reversible leukoencephalopathy syndrome in a patient with end stage renal disease. Intern Med 47:43–45

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rodrigo Alves de Oliveira.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Oliveira, R.A., Fechine, L.M., Neto, F.C. et al. Posterior reversible encephalopathy syndrome (PRES) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis. Int Urol Nephrol 40, 1095–1098 (2008). https://doi.org/10.1007/s11255-008-9431-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-008-9431-y

Keywords

Navigation